WHO expecting more data on Covaxin from Bharat Biotech

Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the WHO on April 19 for its vaccine. 

171
WHO World Health Organisation
Picture: Pixabay

Last Updated on January 6, 2024 by The Health Master

Bharat Biotech has been submitting data to WHO on a rolling basis and agency experts have reviewed these data

The World Health Organization (WHO) on Monday said that it was aware that many people were waiting for its recommendation for Bharat Biotech‘s C-19 vaccine Covaxin to be included in the Emergency Use Listing, but it cannot cut corners.

“Before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective,” it said.

Bharat Biotech has been submitting data to WHO on a rolling basis and WHO experts have reviewed these data. “WHO is expecting one additional piece of information from the company today,” the UN health agency said.

It further said that the timeframe for the Emergency Use Listing procedure is dependent on how quickly a company producing the vaccine is able to provide the data required for WHO to evaluate the vaccine’s quality, safety, efficacy and its suitability for low and middle-income countries.

“When the information provided addresses all questions raised, WHO and the Technical Advisory Group will complete the assessment and come to a final recommendation whether to grant Emergency Use Listing to the vaccine,” it said.

WHO’s chief scientist Soumya Swaminathan has informed that global health agency’s technical advisory group will meet on October 26 to consider the emergency use listing of Covaxin

Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the WHO on April 19 for its vaccine. 

Swaminathan said on Twitter on Sunday that the technical advisory group will meet on October 26 to consider the Emergency Use Listing (EUL) for Covaxin.

“@WHO has been working closely with @BharatBiotech to complete the dossier. Our goal is to have a broad portfolio of vaccines approved for emergency use and to expand access to populations everywhere,” she said in the tweet.

Covishield

Covaxin

Sputnik V

Modenra

Drugs Technical Advisory Board (DTAB): Minutes of meetings

FAQs by CDSCO on Pharma, Cosmetics, MDR, Clinical Trial

Drug Consultative Committee (DCC): Minutes of meetings

Don’t give yourself fillers with these Devices: FDA Says

Afghanistan: Pharmacy union warns of medicine shortage

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news